Experimental vaccine against Marburg virus shows promise in first-in-human clinical trial

smart city and communication network. Smart city dot point connect .internet of things connection metaverse technology.

A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial.

Model Drift: The Achilles Heel of AI Explained

Previous article

Cancer treatments may impair heart function or cause long-term cardiac damage

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News